CNS Pharmaceuticals, Inc.
Hedge Funds Holdings

Last updated:

CNS Pharmaceuticals, Inc.‘s stocks are currently a part of 11 hedge funds’ portfolios, which represents 3.88% of the total amount of its stocks outstanding. This makes up a total of 52.84K shares of CNS Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -62.08% or -86.52K shares fewer. As for the holding position changes, 27.27% (3) of current hedge fund investors increased the number of shares held. 4 hedge funds are new holders of CNS Pharmaceuticals, Inc. stock in Q1 2023, it is 36.36% of total holders.

Hedge funds holding CNS Pharmaceuticals (Q4 2019 – Q1 2023)

Number of hedge funds
Q4 2019 4
Q1 2020 8
Q2 2020 5
Q3 2020 6
Q4 2020 10
Q1 2021 17
Q2 2021 19
Q3 2021 18
Q4 2021 20
Q1 2022 16
Q2 2022 18
Q3 2022 17
Q4 2022 9
Q1 2023 11

Hedge funds changes in CNS Pharmaceuticals positions (Q4 2019 – Q1 2023)

Changes in positions
Q4 2019 40000
Q1 2020 51110
Q2 2020 1014-1
Q3 2020 21111
Q4 2020 50113
Q1 2021 11214-1
Q2 2021 73252
Q3 2021 45252
Q4 2021 63245
Q1 2022 4537-3
Q2 2022 54243
Q3 2022 33146
Q4 2022 90017-17
Q1 2023 43004

Top 50 hedge fund holders of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)